Long term follow-up of Chinese patients with HBeAg-negative chronic hepatitis who discontinued treatment after 2 years of lamivudine monotherapy

被引:0
|
作者
Fung, Scott K.
Wong, Florence
Lok, Anna S.
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Toronto, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
972
引用
收藏
页码:670A / 670A
页数:1
相关论文
共 50 条
  • [1] Discontinuation of lamivudine treatment in HBeAg-negative chronic hepatitis B: a pilot study with long-term follow-up
    Karakaya, Fatih
    Ozer, Sevil
    Kalkan, Cagdas
    Tuzun, E. Ali
    Caliskan, Aysun
    Keskin, Onur
    Kabacam, Gokhan
    Karatayli, Senem
    Karatayli, Ersin
    Bozdayi, A. Mithat
    Idilman, Ramazan
    Yurdaydin, Cihan
    [J]. ANTIVIRAL THERAPY, 2017, 22 (07) : 559 - 570
  • [2] Long-term follow-up of treatment-naive HBeAg-negative patients with chronic hepatitis B
    Ozdemir, Yusuf Emre
    Ozdemir, Meryem Sahin
    Bayramlar, Osman Faruk
    Surme, Serkan
    Kaya, Sibel Yildiz
    Karaali, Ridvan
    Balkan, Ilker Inanc
    Mete, Bilgul
    Saltoglu, Nese
    Tabak, Fehmi
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (02) : 633 - 639
  • [3] LONG-TERM RESPONSE TO LAMIVUDINE MONOTHERAPY IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: TO CHANGE OR NOT TO CHANGE?
    Fasano, Massimo
    Niro, Grazia A.
    Volpe, Anna
    Gaeta, Giovanni B.
    Scotto, Gaetano
    Ippolito, Antonio M.
    Angarano, Gioacchino
    Santantonio, Teresa
    [J]. HEPATOLOGY, 2010, 52 (04) : 527A - 527A
  • [4] Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B
    Yusuf Emre Ozdemir
    Meryem Sahin Ozdemir
    Osman Faruk Bayramlar
    Serkan Surme
    Sibel Yildiz Kaya
    Ridvan Karaali
    Ilker Inanc Balkan
    Bilgul Mete
    Nese Saltoglu
    Fehmi Tabak
    [J]. Irish Journal of Medical Science (1971 -), 2023, 192 : 633 - 639
  • [5] LONG-TERM FOLLOW-UP OF EUROPEAN HBEAG-NEGATIVE CHRONIC HEPATITIS B-INFECTED PATIENTS ON ANTIVIRAL TREATMENT
    Knop, V.
    Welzel, T.
    Schreiber, C.
    Hubrich, U.
    Sprinzl, K.
    Kronenberger, B.
    Zeuzem, S.
    Sarrazin, C.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S603 - S604
  • [6] Long term follow-up of a large cohort of asymptomatic HBeAg-negative chronic hepatitis B carriers
    Raptopoulou-Gigi, M
    Goulis, I
    Orphanou, H
    Lalla, T
    Sinakos, E
    Vakolas, L
    Vrettou, H
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 179 - 179
  • [7] Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B
    Rizzetto, M
    Tassopoulos, NC
    Goldin, RD
    Esteban, R
    Santantonio, T
    Heathcote, EJ
    Lagget, M
    Taak, NK
    Woessner, MA
    Gardner, SD
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 173 - 179
  • [8] Long-term follow-up after initial response to interferon therapy in patients with HBeAg-negative chronic hepatitis B.
    Papatheodoridis, GV
    Manesis, E
    Hadziuannis, SJ
    [J]. HEPATOLOGY, 2000, 32 (04) : 378A - 378A
  • [9] Three-year follow-up of pegylated interferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B
    Papadopoulos, Vasileios
    Protopapas, Andreas
    Tsianos, Epameinondas
    Mimidis, Konstantinos
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (08) : 1021 - 1022
  • [10] Virologic response can be durable in HBeAg positive patients with chronic hepatitis B after lamivudine monotherapy during long-term follow-up?
    Lee, Hyun Woong
    Han, Kwang-Hyub
    Myoung, Sung Min
    Chung, Yun Hee
    Park, Jun Yong
    Lee, Jin Young
    Kim, Ja Kyung
    Ahn, Sang Hoon
    Paik, Yong Han
    Lee, Kwan Sik
    Chon, Chae Yoon
    Moon, Young Myoung
    [J]. HEPATOLOGY, 2006, 44 (04) : 561A - 562A